MCE 的所有產品僅用作科學研究或藥證申報，我們不為任何個人用途提供產品和服務。

Budesonide

CAS No. : 51333-22-3

產品活性：Budesonide, an inhaled glucocortical steroid, is an orally active glucocorticoid receptor agonist. Budesonide decreases the size of lung tumors, reverses DNA hypomethylation and modulates mRNA expression of genes. Budesonide is an anti-inflammatory agent used for asthma.

研究領域：Immunology/Inflammation  |  Vitamin D Related/Nuclear Receptor

作用靶點：Glucocorticoid Receptor

In Vitro: Budesonide is selective for human glucocorticoid receptor (hGR; EC₅₀=45.7 pM) over mineralocorticoid receptors (EC₅₀=7,620 pM) in CV-1 cells.
Budesonide (30?min prior to LPS) suppresses the activation of the NLRP3 inflammasome by LPS (100?ng/mL) plus ATP (5?mM) in macrophages (RAW 264.7 cells).

In Vivo: Budesonide (2.0 mg/kg; orally via their diet; at 2, 7 and 21 days prior to killing) decreases the size of lung tumors.
Budesonide (0.5?mg/kg; intranasal administration 1?h before LPS injection (5?mg/kg)) pretreatment dramatically attenuates pathological injury and reduces pathological scores in mice with ALI in adult male C57BL/6 mice.

相關產品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Antiviral Compound Library  |  Drug Repurposing Compound Library  |  NMPA-Approved Drug Library  |  Orally Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Tumorigenesis-Related Compound Library  |  Rare Diseases Drug Library  |  Children’s Drug Library  |  EMA-Approved Drug Library  |  FDA-Approved Anticancer Drug Library  |  Human Metabolite Library  |  Nuclear Receptor Compound Library  |  Non-steroidal Anti-Inflammatory Compound Library  |  Pain-Related Compound Library  |  Off-patent Drug Library  |  Medroxyprogesterone acetate-d₃  |  Prednisolone acetate  |  Clobetasone butyrate  |  Mifepristone-¹³C,d₃  |  Deflazacort  |  C108297  |  Nenocorilant  |  Methylprednisolone succinate  |  Medroxyprogesterone acetate  |  Betamethasone 21-phosphate-d₅  |  Betamethasone dipropionate-d₁₀  |  Fluticasone propionate-d₅  |  Methylprednisolone-d₅  |  Fluticasone furoate-d₃  |  Dexamethasone-d₄  |  Mizacorat  |  Beclometasone dipropionate  |  Mifepristone-d₃  |  Methylprednisolone-d₂  |  Beclometasone dipropionate-d₁₀  |  Prednisone-d₈  |  Prednisolone Tebutate  |  Hydrocortisone hemisuccinate  |  Betamethasone-d₅-1  |  OP-3633  |  Glucocorticoid receptor agonist-1  |  Triamcinolone Benetonide

熱門產品線：重組蛋白  |  化合物庫  |  天然產物  |  熒光染料  |  PROTAC  |  同位素標記物  |  寡核苷酸  |  抗體  |  點擊化學

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種*僅有化合物庫，我們致力于為*科研客戶提供前沿的高品質小分子活性化合物；
•   50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領；
•   產品種類涵蓋各種重組蛋白，多肽，常用試劑盒 ，更有 PROTAC、ADC 等特色產品，廣泛應用于新藥研發、生命科學等科研項目；
•   提供虛擬篩選，離子通道篩選，代謝組學分析檢測分析，藥物篩選等專業技術服務；
•   設有專業的實驗中心和嚴格的質控、驗證體系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質檢報告，確保產品的高純度、高品質；
•   產品的生物活性多經各國客戶實驗驗證；
•   Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果；
•   專業團隊跟蹤新的制藥及生命科學研究進展，為您提供*新的活性化合物；
•   與世界各大制藥公司及*科研機構建立了長期的合作。